Step 1
Unite with Fellow Investors
Step 2
Choose the Best Attorney
Step 3
Provide Documents
Step 4
Follow Case Progress
Step 5
Get Payout
JNCE.US
id: 608, Created by Stan Vick Chase, Scout
Join $JNCE & $GMED M&A Case to Fight Losses
How it works?
- We find Attorney for the Case
- Attorney files case on behalf of Investors
- You get updates and receive payout in case of success
Would it cost me anything?
- No, you do not pay anything out of your pocket neither to us, nor to Attorney
- Attorneys get % fee in case of success
- Platform charges service fee from Attorneys
What are the chances for success?
Every Case is unique, but statistically, 47% of Cases end up with a settlement.
Please see below recent successful cases:
How it works?
- We find Attorney for the Case
- Attorney files case on behalf of Investors
- You get updates and receive payout in case of success
Would it cost me anything?
- No, you do not pay anything out of your pocket neither to us, nor to Attorney
- Attorneys get % fee in case of success
- Platform charges service fee from Attorneys
What are the chances for success?
Every Case is unique, but statistically, 47% of Cases end up with a settlement.
Please see below recent successful cases:
- #JounceTherapeutics, Inc. and #RedxPharma announced an all-share merger.
- $JNCE shareholders will own approximately 37% in the new Co.
- #Investors suspect that the pricing terms of the $JNCE & $REDX M&A deal are #unfair.
On February 2023, cancer treatment-focused Jounce Therapeutics, Inc. (JNCE) and British pharmaceutical company Redx Pharma (REDX) announced their plans for an all-share merger, which will result in the formation of a new entity known as Redx Inc. and its leadership will be headed by current Redx CEO Lisa Anson.
- Under the terms of the merger agreement, Redx shareholders will receive 0.2105 Jounce shares for each Redx share. However, if Jounce approves the reverse stock split, the exchange rate will be adjusted to 0.0421 Jounce shares for each Redx share.
- After the deal is completed, which is projected to take place in the second quarter, $REDX shareholders are expected to own approximately 63% of Redx Inc., while $JNCE shareholders will own approximately 37%.
Investors of #Jounce may have reasons to suspect that the pricing terms of the M&A transaction are unfair and that the Company BoD breached fiduciary duties to shareholders.
Alleged Offence
Mismanagement,
Financial Misrepresentation,
Failure to Disclose,
Malpractice,
Negligence,
Breach of Fiduciary duty,
Omissions
Suspected Party
Directors,
Management,
Shareholder,
Investment Bank,
Service Provider
Security Type
Stocks
Trade Direction
Long
Shock Event Date
09 March 2023